Huidong Shi

Activation of Gpr109a, Receptor for Niacin and the Commensal Metabolite Butyrate, Suppresses Colonic Inflammation and Carcinogenesis

Nagendra Singh, Ashish Gurav, Sathish Sivaprakasam et al. · Immunity · 2014 · 2.3K citations · Full text

Life Sciences, Cancer Biology, Nutritional Sciences +14

Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells

Warren Fiskus, Yongchao Wang, Arun Sreekumar et al. · Blood · 2009 · 358 citations · Full text

Medicine, Oncology, Pharmacology +17

The MLL1-H3K4me3 Axis-Mediated PD-L1 Expression and Pancreatic Cancer Immune Evasion

Chunwan Lu, Amy V. Paschall, Huidong Shi et al. · JNCI Journal of the National Cancer Institute · 2016 · 288 citations · Full text

Life Sciences, Immunology, Oncology +14

Methylation-Specific Oligonucleotide Microarray: A New Potential for High-Throughput Methylation Analysis

Raad S. Gitan, Huidong Shi, Chuan‐Mu Chen et al. · Genome Research · 2001 · 281 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Butyrate suppresses colonic inflammation through HDAC1-dependent Fas upregulation and Fas-mediated apoptosis of T cells

Mary Ann Zimmerman, Nagendra Singh, Pamela M. Martin et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 2012 · 277 citations · Full text

Life Sciences, Immunology, Nutritional Sciences +17